Lufax Faces Class Action Lawsuit Reminder for Investors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 11 2026
0mins
Should l Buy LU?
Source: Globenewswire
- Class Action Notification: The Schall Law Firm reminds investors that Lufax is facing a class action lawsuit for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between April 7, 2023, and January 26, 2025, with a deadline to contact the firm by May 20, 2026.
- False Statement Allegations: The complaint alleges that Lufax made false and misleading statements during the class period, failing to maintain adequate internal controls, which resulted in materially misstated financial results that misled investors.
- Loss Recovery Opportunity: Investors are encouraged to join the lawsuit to recover losses, with the Schall Law Firm specializing in securities class actions and offering free consultations to help affected shareholders understand their rights.
- Lawsuit Status Explanation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act will remain absent class members.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Reminder: The Schall Law Firm reminds investors of a class action lawsuit against Lufax Holding Ltd for violations of §§10(b) and 20(a) of the Securities Exchange Act, involving securities purchased between April 7, 2023, and January 26, 2025, indicating significant legal risks for the company.
- False Statements Allegations: The complaint alleges that Lufax made false and misleading statements during the class period, failed to maintain adequate internal controls, and materially misstated financial results, which could lead to substantial losses for investors.
- Investor Losses: Following the revelation of Lufax's true situation, investors suffered damages, and the Schall Law Firm encourages affected shareholders to contact them before May 20, 2026, to participate in the lawsuit and seek recovery of their losses.
- Legal Consultation Opportunity: The Schall Law Firm offers free legal consultations, allowing investors to reach out via phone or website to understand their rights and potential legal remedies.
See More
- Class Action Initiated: Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Lufax and certain executives, seeking damages for investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, highlighting serious concerns over corporate governance and financial transparency.
- Detailed Allegations: The complaint alleges that Lufax lacked adequate internal controls and materially misstated financial results, leading to misleading statements from executives that could result in significant losses for investors, indicating a potential breach of trust.
- Urgent Investor Action Required: Affected investors must apply by May 20, 2026, to be appointed as lead plaintiffs to share in any potential recovery, reflecting the urgency of legal proceedings in protecting investor rights and interests.
- Law Firm's Credentials: Bronstein, Gewirtz & Grossman LLC is recognized for recovering hundreds of millions for investors, emphasizing its expertise in securities fraud class actions and its commitment to restoring investor capital and ensuring corporate accountability.
See More
- Lawsuit Background: Lufax announced the removal of its auditor on January 27, 2025, due to concerns over undisclosed related-party transactions, triggering a nearly 14% drop in share price that day, reflecting severe investor concerns about the company's financial transparency.
- Internal Control Deficiencies: The class action alleges that Lufax lacked adequate internal controls and materially misstated its financial results, potentially exacerbating losses for investors who purchased shares between April 2023 and January 2025.
- Auditor Opinion Rejection: PwC has refused to allow its previous audit opinions to be incorporated into any future company filings, indicating a complete loss of trust in Lufax's 2022 and 2023 financial statements, which could lead to further legal and financial repercussions.
- Ongoing Investigation: Hagens Berman is investigating whether Lufax intentionally violated accounting rules and disclosure requirements, and if proven, this could have significant implications for the company's future operations and shareholder confidence.
See More
- Legal Investigation Launched: Faruqi & Faruqi LLP is investigating Lufax Holding Ltd. for potential violations of federal securities laws between April 7, 2023, and January 26, 2025, with a deadline of May 20, 2026, for investors to apply as lead plaintiffs in a class action to protect their rights.
- Allegations of Financial Misstatements: The lawsuit alleges that Lufax and its executives failed to disclose inadequate internal controls and materially misstated financial results, leading to significant misrepresentation of the company's business and prospects, which could result in investor losses.
- Stock Price Impact: On January 27, 2025, following the disclosure of the board's proposal to remove auditors, Lufax's American Depositary Shares (ADS) fell by $0.40, or 13.8%, closing at $2.49, reflecting market concerns over the company's financial transparency.
- Investor Rights Protection: Faruqi & Faruqi encourages anyone with information regarding Lufax's conduct, including whistleblowers and former employees, to come forward to provide legal support for affected investors, ensuring their rights are upheld.
See More
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Lufax Holding Ltd., alleging securities fraud and other unlawful business practices, with investors needing to apply as Lead Plaintiff by May 20, 2026.
- Auditor Replacement Crisis: On January 27, 2025, Lufax proposed to replace its auditor, PricewaterhouseCoopers, due to significant concerns regarding the reliability of its 2022 and 2023 financial reports, raising further questions about the company's financial transparency.
- Stock Price Volatility: Following the auditor change announcement, Lufax's American Depositary Share price plummeted nearly 22% over three trading sessions, indicating strong investor concerns about the company's financial health and a sharp decline in market confidence.
- Law Firm Background: Pomerantz LLP is a prominent class action law firm with over 85 years of experience in corporate, securities, and antitrust litigation, dedicated to fighting for the rights of victims of securities fraud, showcasing its expertise and influence in such cases.
See More
- Lawsuit Background: Lufax announced the removal of its auditor on January 27, 2025, due to concerns over undisclosed related-party transactions, triggering a nearly 14% drop in share price that day and raising investor doubts about the company's financial transparency.
- Legal Action: Hagens Berman has filed a securities class action lawsuit against Lufax on behalf of investors who purchased its securities between April 7, 2023, and January 26, 2025, alleging violations of federal securities laws and encouraging affected investors to submit their losses.
- Auditor Issues: Lufax's auditor, PwC, raised concerns about the reliability of the company's financial statements before its dismissal, stating it could not rely on the company's representations regarding its 2022 and 2023 financials, further exacerbating market worries about the company's financial health.
- Transaction Transparency: On April 23, 2025, Lufax revealed it engaged in a series of complex transactions from May 2023 to June 2024, involving asset purchases from affiliated entities, leading to significant misstatements in its balance sheet that could undermine investor confidence and future financing capabilities.
See More











